全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1416990-08-3 | 3-(5-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;3-(6-hydroxy-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H12N2O4 |
| 1416990-09-4 | 3-(6-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;3-(5-hydroxy-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H12N2O4 |
| 1416992-39-6 | GC376 sodium;Sodium (2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate | C21H30N3NaO8S |
| 1417162-36-7 | 1-(3,4-Dichlorophenyl)-3-(4-methoxyphenyl)-4-(4-morpholinyl)-1H-pyrrole-2,5-dione | C21H18Cl2N2O4 |
| 1417329-24-8 | 1-[[(2S)-5-[(Aminoiminomethyl)amino]-2-[[2-ethyl-2-[(2-methyl-1-oxopropyl)amino]-1-oxobutyl]amino]-1-oxopentyl]amino]-N-[bis(4-fluorophenyl)methyl]cyclopentanecarboxamide] | C35H49F2N7O4 |
| 1417456-04-2 | 2-Amino-6-fluoro-N-phenylbenzamide | C13H11FN2O |
| 1417567-41-9 | 1-Bromo-3-chloro-5-(trifluoromethoxy)benzene | C7H3BrClF3O |
| 1417576-00-1 | Azilsartan Impurity 6;(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-oxo-3-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-2,3-dihydro-1H-benzimidazole-4-carboxylate | C28H20N4O8 |
| 1417633-09-0 | 7-Oxa-2-azaspiro[3.5]nonane hydrochloride | C7H13NO.HCl |
| 1417788-92-1 | (3R)-3-[(1R)-1-Methylpropyl]morpholine | C8H17NO |
| 1417789-45-7 | (2S)-2-Morpholinecarboxylic acid methyl ester hydrochloride (1:1) | C6H11NO3.HCl |
| 1417789-49-1 | (1S,6R)-3,7-Diazabicyclo[4.2.0]octane-3-carboxylic acid 1,1-dimethylethyl ester | C11H20N2O2 |
| 1417789-75-3 | tert-Butyl (3S,4S)-3-(hydroxymethyl)-4-methyl-pyrrolidine-1-carboxylate | C11H21NO3 |
| 1417859-62-1 | (3S)-4-(Phenylmethyl)-3-morpholinemethanamine | C12H18N2O |
| 1417997-93-3 | (2E)-N-Hydroxy-3-(5-methoxy[1,1':4',1''-terphenyl]-2-yl)-2-propenamide | C22H19NO3 |
| 1418013-75-8 | 3-[3-(Cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]pyridine | C27H28N4O3S2 |
| 1418033-25-6 | N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-benzamide | C15H22N2O4 |
| 1418131-46-0 | RSC 133 | C18H15N3O2 |
| 1418144-62-3 | 1-[3-Bromo-4-(hydroxymethyl)phenyl]ethanone | C9H9BrO2 |
| 1418144-66-7 | Siponimod Alcohol Impurity;(E)-1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethan-1-one O-(4-cyclohexyl-3-(trifluoromethyl)benzyl) oxime | C25H30F3NO2 |
| 1418307-17-1 | (S)-Benzyl 2-((3-chloropyrazin-2-yl)methylcarbamoyl)pyrrolidine-1-carboxylate | C18H19ClN4O3 |
| 1418307-18-2 | (2S)-2-(8-Chloroimidazo[1,5-a]pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C18H17ClN4O2 |
| 1418308-27-6 | 6-Cyano-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-1-(1-ethylpropyl)-1H-indole-4-carboxamide | C23H26N4O2 |
| 1418741-86-2 | 1,1'-(1,4-Phenylene)bis[1-[1,4'-bipiperidin]-1'-ylmethanone] | C28H42N4O2 |
| 1419075-88-9 | 4-(1,3,4-Oxadiazol-2-yl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C12H19N3O3 |
| 1419949-20-4 | N-Cyclopropylmethyl-2-[4-(4-methoxybenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrimidin-2-yl)methyl]acetamide | C27H34N4O5 |
| 1420071-30-2 | Bioymifi;5-[5-[[(5Z)-3-(4-Bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene]methyl]-2-furanyl]-1H-isoindole-1,3(2H)-dione | C22H12BrN3O4S |
| 1420290-99-8 | 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride (1:1) | C15H13Cl2N3O4.HCl |
| 1420477-60-6 | Acalabrutinib;4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196 | C26H23N7O2 |
| 1420478-87-0 | (2S)-2-(1-Bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C18H16BrClN4O2 |
| 1420478-88-1 | (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate;benzyl (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | C18H18BrN5O2 |
| 1420478-89-2 | (2S)-2-[8-Amino-1-[4-[(2-pyridinylamino)carbonyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-pyrrolidinecarboxylic acid phenylmethyl ester | C30H27N7O3 |
| 1420478-90-5 | 4-[8-Amino-3-(2S)-2-pyrrolidinylimidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide | C22H21N7O |
| 1420623-75-1 | Imidazo[1,2-b]pyridazine-3-carboxylic acid ethyl ester | C9H9N3O2 |
| 1420685-39-7 | (4-Bromo-3-fluorophenyl)hydrazine hydrochloride | C6H6BrFN2.HCl |
| 1420800-16-3 | Oxetane-3-carbonitrile | C4H5NO |
| 1420987-86-5 | Brexpiprazole Impurity 1;1,4-Di(benzo[b]thiophen-4-yl)piperazine | C20H18N2S2 |
| 1420999-91-2 | N-(1-Acetyl-2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-chloro-3-pyridinecarboxamide | C18H18ClN3O2 |
| 1421227-52-2 | N-[6-[4-[[[[4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]cyclopropanecarboxamide | C28H30F3N7O3 |
| 1421227-53-3 | 4-[[6-[(Cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzeneacetamide | C29H31F3N6O3 |
| 1421312-34-6 | 4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester | C18H15NO4 |
| 1421313-98-5 | 7-Oxo-2-azaspiro[4.5]decane-2-carboxylic acid 1,1-dimethylethyl ester | C14H23NO3 |
| 1421338-17-1 | 4-chloro-5-nitro-1-tosyl-1H-pyrrolo[2,3-b]pyridine | C14H10ClN3O4S |
| 1421341-05-0 | 3-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4(3H)-quinazolinone | C15H19BN2O3 |
| 1421372-66-8 | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine;Mutated EGFR-IN-1 | C25H31N7O |
| 1421372-67-9 | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine | C25H29N7O3 |
| 1421372-94-2 | N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine | C20H16FN5O3 |
| 1421373-36-5 | 3-Chloro-N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]propanamide | C28H34ClN7O2 |
| 1421373-62-7 | N-[5-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-2-propenamide;Mutant EGFR inhibitor | C27H30ClN7O2 |
| 1421373-65-0 | N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;osimertinib | C28H33N7O2 |